Disclosure Plus

Y-Biologics, Inc. Shifts to Co-CEO Structure with Park Young-woo and Park Beom-chan

[Edaily Reporter Park Sun-Yeop ] Y-Biologics, Inc(338840)announced on the 3rd that its CEO structure has changed from the previous co-CEO system of Park Young-woo and Jang Woo-ik to a co-CEO system of Park Young-woo and Park Beom-chan.
The change was due to the resignation of CEO Jang Woo-ik for personal reasons and the new appointment of CEO Park Beom-chan.
Former CEO Jang Woo-ik has resigned from both his positions as CEO and as an inside director.

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02